Skip to content

Clinical trials

Endocrine System Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endocrine System Diseases Country / region: Germany Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20103
20131
20141
20152
20161
20173
20192
20202
20212
20221
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting6
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Eli Lilly and Company3
Ascendis Pharma A/S2
Ascendis Pharma Endocrinology Division A/S2
Charite University, Berlin, Germany2
Pfizer2
AbbVie1
Alexion Pharmaceuticals, Inc.1
Aphaia Pharma US LLC1
Ascendis Pharma Bone Diseases A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endocrine System Diseases25
Diabetes Mellitus8
Diabetes Mellitus, Type 28
Glucose Metabolism Disorders7
Metabolic Diseases7
Endocrine Gland Neoplasms6
Neoplasms6
Neoplasms by Site6
Obesity5
Adenocarcinoma4

Trials

Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.